CDC, Hepatitis B Foundation, and CHIPO Release New African Know Hepatitis B Materials

In the U.S., African immigrants are disproportionately impacted by hepatitis B, with 5 to 18 percent of African immigrants estimated to be living with chronic hepatitis B and at increased risk of liver disease, liver cancer, and death.

As an extension of the Know Hepatitis B Campaign, the Centers for Disease Control and Prevention (CDC) in partnership with the Hepatitis B Foundation and the Coalition Against Hepatitis for People of African Origin (CHIPO) has released new educational materials focused on African immigrant communities.

Resources include a digital self-guided PowerPoint for community health workers; a printable flipchart for face-to-face community education; informational fact sheets; resources for locating hepatitis B testing; and a digital resource toolkit featuring #justB storytelling videos.

Access the materials here.

Improving Diversity in Clinical Trials for Hepatitis B Treatments

Join Hep B United on Wednesday, March 11th at 3:00 PM EST for a webinar to discuss why representation, including of persons living with hepatitis B, is essential to research, and communication and outreach strategies to improve diversity in clinical trials! Christine Lee, PharmaD, PhD, from the U.S. Food & Drug Administration (FDA) will be providing an overview of clinical trials recruitment and strategies to improve participation and Rhea Racho, MPAff, will discuss the Hepatitis B Foundation’s participation in the National Institute of Health’s All of Us Research Program and how the program is working to make medical research more inclusive.

Register here.